{"id":11216,"date":"2026-07-16T01:23:57","date_gmt":"2026-07-16T01:23:57","guid":{"rendered":"https:\/\/stock999.top\/?p=11216"},"modified":"2026-07-16T01:23:57","modified_gmt":"2026-07-16T01:23:57","slug":"tom-brady-joins-emed-to-help-expand-glp-1-access-and-fight-obesity","status":"publish","type":"post","link":"https:\/\/stock999.top\/?p=11216","title":{"rendered":"Tom Brady joins eMed to help expand GLP-1 access and fight obesity"},"content":{"rendered":"<p><img src=\"https:\/\/static.foxbusiness.com\/foxbusiness.com\/content\/uploads\/2026\/07\/tom-brady-nfl.png\" \/>     <\/p>\n<p>NFL legend and eMed Chief Wellness Officer Tom Brady and eMed CEO Linda Yaccarino discuss eMed&#8217;s mission on &#8216;The Claman Countdown.&#8217;<\/p>\n<p>As GLP-1 weight loss medications continue to surge in popularity, NFL legend Tom Brady is getting in on the action, using his wellness brand to &#8220;democratize&#8221; the health care system in a way the world has &#8220;never seen.&#8221;<\/p>\n<p>The seven-time Super Bowl champion has teamed up with eMed, a digital health company managing sustainable ways to offer GLP-1 drugs while helping employers reduce health insurance claims.<\/p>\n<p>&#8220;There&#8217;s an epidemic in America, the disease of obesity, and how can we democratize health and wellness in a way that the world has never seen?&#8221; Brady said in an exclusive interview with &#8220;The Claman Countdown&#8221; Wednesday.<\/p>\n<p>DR OZ LINKS OBESITY TO CHRONIC DISEASE SURGE, SAYS GLP-1S CAN &#8216;JUMPSTART&#8217; BETTER HEALTH<\/p>\n<p>Tom Brady before a game at AT&amp;T Stadium Sept, 15, 2024, in Arlington, Texas. (Sam Hodde\/Getty Images \/ Getty Images)<\/p>\n<p>Serving as eMed\u2019s chief wellness officer, Brady hopes to help people live better, healthier lives by harnessing the power of weight loss medications, lamenting America\u2019s obesity epidemic.<\/p>\n<p>&#8220;I love seeing people live a better life, live a healthier life, feel better, do the things that they want to do in the end. It&#8217;s always been a struggle in our country,&#8221; the football legend said.<\/p>\n<p>&#8220;There&#8217;s no debate about the way that this medicine is working right now in terms of keeping people and getting people on their wellness journey started.&#8221;<\/p>\n<p>TOM BRADY LAUNCHES GOOD NUT COCONUT WATER LINE WITH GOPUFF IN MARKET EXPECTED TO REACH $11B BY 2030<\/p>\n<p>EMed CEO Linda Yaccarino previously said the goal is to apply Brady\u2019s &#8220;rigor&#8221; to improve the health of the American workforce and minimize chronic diseases.<\/p>\n<p>A woman injects a GLP-1 into her stomach in this undated photo taken at an undisclosed location. (iStock \/ iStock)<\/p>\n<p>With more than 60% of Americans receiving health benefits through an employer, eMed aims to incentivize companies to cover GLP-1 medications for eligible workers, Yaccarino said.<\/p>\n<p>&#8220;We do a great job of saving employers&#8217; money and getting people healthy,&#8221; Brady said.<\/p>\n<p>AMERICANS ARE GIVING UP MULTIVITAMINS FOR A DIFFERENT DAILY HEALTH HABIT, STUDY FINDS<\/p>\n<p>&#8220;There&#8217;s finally, for the first time, a health benefit, attacking all these chronic diseases and a financial benefit to employers. So, it&#8217;s giving them incentive to cover the medications,&#8221; Yaccarino added.<\/p>\n<p>Tom Brady shakes a young fan&#8217;s hand at Fanatics Fest. (Fanatics \/ Fox News)<\/p>\n<p>GET FOX BUSINESS ON THE GO BY CLICKING HERE<\/p>\n<p>Yaccarino described GLP-1 medications as the &#8220;pharmaceutical revolution&#8221; of the modern age while outlining the support eMed provides to patients.<\/p>\n<p>&#8220;Once we bring our members onto our program, we combine AI, technology and continuous clinical support so they stay with us,&#8221; she said.<\/p>\n<p>#Tom #Brady #joins #eMed #expand #GLP1 #access #fight #obesity<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NFL legend and eMed Chief Wellness Officer Tom Brady and eMed CEO Linda Yaccarino discuss&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[2275,5621,17182,1296,463,5622,1242,10929,5620],"_links":{"self":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/11216"}],"collection":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11216"}],"version-history":[{"count":0,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/11216\/revisions"}],"wp:attachment":[{"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}